Bone mineral density, vitamin D and anticonvulsant therapy
Arq. neuropsiquiatr
;
58(3A): 616-20, set. 2000. tab
Article
Dans Anglais
| LILACS
| ID: lil-269606
RESUMO
The aim of this study was to assess bone mineral density and vitamin D metabolism in patients on chronic anticonvulsant therapy. METHODS:
Sixty-nine men, outpatients on chronic anticonvulsant therapy, who had been treated for at least 5 years, were studied, comparing them to thirty healthy controls. Bone mineral density was measured as well as serum levels of calcium, ionized calcium, alkaline phosphatase, PTH, 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol.RESULTS:
No differences in bone mineral density, serum levels of vitamin D and intact-PTH were observed between patients and controls. Bone mineral density was not associated with chronic anticonvulsant therapy.CONCLUSION:
Those adult patients who were on chronic anticonvulsant therapy and who lived in low latitude regions had normal bone mineral density as well as vitamin D serum levels
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Phénobarbital
/
Phénytoïne
/
Vitamine D
/
Carbamazépine
/
Densité osseuse
/
Épilepsie
/
Anticonvulsivants
Type d'étude:
Étude observationnelle
/
Facteurs de risque
Limites du sujet:
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Arq. neuropsiquiatr
Thème du journal:
Neurologie
/
Psychiatrie
Année:
2000
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Universidade Estadual de Campinas/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS